Thoracolumbar Fascia Release on Pulmonary Function in Stroke
TLF-STROKE
Immediate Effects of Thoracolumbar Fascia Release on Pulmonary Function in Stroke Patients: a Randomized Controlled Study
1 other identifier
interventional
42
1 country
1
Brief Summary
This study looks at how thoracolumbar fascia release affects breathing in people who had a stroke. After a stroke, many people have trouble breathing well because their muscles become stiff. We want to see if releasing the thoracolumbar fascia (a big sheet of tissue in the lower back) can help improve lung function. Participants will be divided into three groups: Control group - Receives standard stroke rehabilitation. Breathing exercise group - Gets standard rehabilitation plus breathing exercises. Thoracolumbar fascia release group - Gets standard rehabilitation plus thoracolumbar fascia release therapy. We will measure lung function right after a single session to see if this therapy makes breathing easier. Our primary outcome is to check if thoracolumbar fascia release improves lung function compared to the other groups. This study hopes to find new ways to help stroke survivors breathe better and feel more comfortable.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable stroke
Started Nov 2022
Typical duration for not_applicable stroke
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2024
CompletedFirst Submitted
Initial submission to the registry
February 17, 2025
CompletedFirst Posted
Study publicly available on registry
February 21, 2025
CompletedFebruary 21, 2025
February 1, 2025
1.6 years
February 17, 2025
February 17, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Pulmonary Function
Spirometric measurements were performed by respiratory physical therapist using COSMED Pony FX spirometer (Elsa Medical Ltd., Rome, Italy) portable device. FEV1(%), FVC (%) and FEV1/FVC and PEF (%) were taken to assess the pulmonary functions.
From enrollment to the immediately after one session of treatment in all groups
Study Arms (3)
Traditional stroke rehabilitation
EXPERIMENTALTraditional personalized stroke rehabilitation
Thoracolumbar fascia release
EXPERIMENTALTraditional personalized stroke rehabilitation plus thorakolumbar fascia release
Respiratory exercise
EXPERIMENTALTraditional personalized stroke rehabilitation plus respiratory exercise
Interventions
Personalized traditional stroke rehabilitation programme including spasticity inhibition, sensory-perceptual-motor integration techniques, core stabilization and strengthening exercises, balance training i.e. applied as needed for stroke patients approximately for 45 minutes
Thoracolumbar fascia release was performed by physiotherapist for one session. Supine Pelvic Rotation, Supine Arm Elevation, Bending Forward in Sitting Position and Sitting Crossed Arm and Knee Positions were performed approximately for 10-15 minutes after 45 minutes of traditional stroke rehabilitation.
Respiratory exercises were performed by physiotherapist for one session. Pursed-Lip Breathing, Deep Breathing Exercise, Diaphragm Strengthening Exercise and Thoracic Expansion Exercises were performed approximately for 10-15 minutes after 45 minutes of traditional stroke rehabilitation.
Eligibility Criteria
You may qualify if:
- Eligible participants were male patients aged 18-65 years, diagnosed with monohemispheric ischemic stroke above the brainstem, confirmed through computed tomography or magnetic resonance imaging and a stroke diagnosis at least six months prior to the study.
You may not qualify if:
- Severe cardiorespiratory or neuromuscular disease, tracheostomy, obesity (BMI ≥30 kg/m²), rib cage deformity, cognitive impairment (Mini-Mental State Examination score ≤ 20), and severe dysphagia, aphasia or confusion.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Kocaeli Sağlık ve Teknoloji Üniversitesilead
- İnönü Üniversitesicollaborator
Study Sites (1)
Kocaeli Sağlık ve Teknoloji Üniversitesi
Kocaeli, Turkey (Türkiye)
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 17, 2025
First Posted
February 21, 2025
Study Start
November 1, 2022
Primary Completion
June 1, 2024
Study Completion
December 1, 2024
Last Updated
February 21, 2025
Record last verified: 2025-02